Jörg Vogel und Linda Popella forschen an einer neuen Klasse von Antibiotika.
Jörg Vogel und Linda Popella forschen an einer neuen Klasse von Antibiotika. Similar to vaccines against the coronavirus, RNA-based antibiotics could decisively advance medicine. Research teams from Würzburg have investigated the requirements they must fulfill to achieve this. In the fight against the corona pandemic, mRNA-based drugs have impressively demonstrated their capabilities. Using this technology, scientists were able to develop and market vaccines against SARS-CoV-2 in record time that are highly effective in protecting millions of people from severe disease. However, RNA-based medicine can be used to combat more than just viruses. Among other things, they are also considered candidates for a new form of antibiotics that can be used to treat bacterial infections in a mag-tailored manner.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
